builderall

Upon completion of this activity, participants should be able to:

  • Employ an understanding of personalized medicine to individualize the use of available drugs in oncology.

  • Communicate the efficacy, safety and side effects of the drugs discussed in emerging treatments.

  • Describe current data on the efficacy and safety of tumor immunotherapy and consider this information when counseling patients regarding clinical trial participation.

  • Identify the emerging and standard diagnostic tests used to assist in planning therapy for their patients.

  • Formulate management strategies for lung, gastrointestinal, genitourinary and breast cancer, considering the contributory roles of local and systemic therapy.

  • Discuss current data on clinical trials evaluating novel investigational agents in lung, gastrointestinal, genitourinary and breast cancer to help clinicians counsel appropriately selected patients about availability and participation.